Pharmacists in West Liberty, KY Accepting Medicare

8 Pharmacists found. Showing 1 - 8

Mrs. Lesa Keaton Mattingly, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 412 Liberty Road, West Liberty, KY 41472 Phone: 606-743-4957

Donna Jean Anderson Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 275 Prestonsburg St, West Liberty, KY 41472 Phone: 606-743-3425

Aaron Hutchinson Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 414 Main St, West Liberty, KY 41472 Phone: 606-743-3163

Michael R Allen, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 275 Prestonsburg St, West Liberty, KY 41472 Phone: 606-743-3425

Dr. Michael Blake Cantrell, PHARMD Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 476 Liberty Rd, West Liberty, KY 41472 Phone: 606-743-3186

David Wayne O'quinn Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 412 Liberty Rd, West Liberty, KY 41472 Phone: 606-356-7605    Fax: 606-743-2187

Dr. Jana Renee Back, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 275 Prestonsburg St, West Liberty, KY 41472 Phone: 606-743-3425    Fax: 606-743-1936

Becky Jean Cook Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 58 Stacy St, West Liberty, KY 41472 Phone: 606-362-7129

News Archive

Feinstein Institute scientists seek sisters for lupus study

The SisSLE (Sisters of Women with Systemic Lupus Erythematosus) research study is looking for sisters: one with a diagnosis of systemic lupus erythematosus (SLE), an autoimmune disease and one (or more) who does not have lupus.

Patients with rare diseases and congress square off over orphan drug tax credits

As President Donald Trump talked tax reform on Capitol Hill Tuesday, Arkansas patient advocate Andrea Taylor was also meeting with lawmakers and asking them to save a corporate tax credit for rare disease drug companies.

RedHill presents positive Phase 2 results for oral opaganib in patients with COVID-19 pneumonia

RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced presentation of the positive Phase 2 safety and efficacy data for oral opaganib (Yeliva®, ABC294640) in hospitalized patients with COVID-19 pneumonia at the World Microbe Forum (WMF) 2021 (poster #: 5574).

Opinion: Governments must take 'concrete action' to reduce maternal mortality, morbidity

With the U.N. Human Rights Council's June session coming up, governments have a "chance to prove that they value women's lives by taking concrete action" to recognize "preventable maternal death as a violation of women's rights," Mary Robinson and Alicia Yamin, advisory council members of the International Initiative on Maternal Mortality and Human Rights, write in a Boston Globe opinion piece.

Read more Medical News

› Verified 4 days ago